168 related articles for article (PubMed ID: 1461293)
1. [Intellectual development of patients with phenylketonuria; 15-year national screening in The Netherlands].
Huisman J; van der Schot LW; Hendrikx MM; Kalverboer AF; Slijper FM
Ned Tijdschr Geneeskd; 1992 Nov; 136(46):2277-81. PubMed ID: 1461293
[TBL] [Abstract][Full Text] [Related]
2. [Intellectual development of phenylketonuria children treated early--a longitudinal study. 10 years' concomitant psychological study in The Netherlands].
Slijper FM; Huisman J; Hendrikx MM; Kalverboer AF; van der Schot L
Monatsschr Kinderheilkd; 1989 Oct; 137(10):662-5. PubMed ID: 2586531
[TBL] [Abstract][Full Text] [Related]
3. Phenylalanine hydroxylase deficiency: intelligence of patients after early dietary treatment.
Chien YH; Chiang SC; Huang A; Lin JM; Chiu YN; Chou SP; Wang TR; Hwu WL
Acta Paediatr Taiwan; 2004; 45(6):320-3. PubMed ID: 15868846
[TBL] [Abstract][Full Text] [Related]
4. International collaborative study of intracytoplasmic sperm injection-conceived, in vitro fertilization-conceived, and naturally conceived 5-year-old child outcomes: cognitive and motor assessments.
Ponjaert-Kristoffersen I; Bonduelle M; Barnes J; Nekkebroeck J; Loft A; Wennerholm UB; Tarlatzis BC; Peters C; Hagberg BS; Berner A; Sutcliffe AG
Pediatrics; 2005 Mar; 115(3):e283-9. PubMed ID: 15741353
[TBL] [Abstract][Full Text] [Related]
5. Growth development and its relationship to intellectual functioning of children with phenylketonuria.
Chang PN; Weisberg S; Fisch RO
J Dev Behav Pediatr; 1984 Jun; 5(3):127-31. PubMed ID: 6736258
[TBL] [Abstract][Full Text] [Related]
6. [20-year national screening for phenylketonuria in The Netherlands. National Guidance Commission PKU].
Verkerk PH
Ned Tijdschr Geneeskd; 1995 Nov; 139(45):2302-5. PubMed ID: 7501062
[TBL] [Abstract][Full Text] [Related]
7. Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies.
Roizen N; Kasza K; Karrison T; Mets M; Noble AG; Boyer K; Swisher C; Meier P; Remington J; Jalbrzikowski J; McLeod R; Kipp M; Rabiah P; Chamot D; Estes R; Cezar S; Mack D; Pfiffner L; Stein M; Danis B; Patel D; Hopkins J; Holfels E; Stein L; Withers S; Cameron A; Perkins J; Heydemann P
Pediatrics; 2006 Aug; 118(2):e379-90. PubMed ID: 16864640
[TBL] [Abstract][Full Text] [Related]
8. [The IQ of heterozygotes for phenylketonuria (PKU). indication of a blood phenylalanine-independent action of the PKU mutant (author's transl)].
Thalhammer O; Havelec L; Knoll E; Wehle E
Wien Klin Wochenschr; 1977 Oct; 89(20):684-6. PubMed ID: 930099
[TBL] [Abstract][Full Text] [Related]
9. Phenylketonuria and its variants: observations on intellectual functioning.
Netley C; Hanley WB; Rudner HL
Can Med Assoc J; 1984 Oct; 131(7):751-5. PubMed ID: 6478363
[TBL] [Abstract][Full Text] [Related]
10. [An eighteen-year study on phenylketonuria].
Yu WM; Xu L; Li XW; He C; Shen M; Zhang ZX; Jin YY; Zhou ZS; Qiao F
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):218-22. PubMed ID: 12905726
[TBL] [Abstract][Full Text] [Related]
11. Transitory hyperphenylalaninaemia in children with continuously treated phenylketonuria.
Griffiths P; Smith C; Harvie A
Am J Ment Retard; 1997 Jul; 102(1):27-36. PubMed ID: 9241405
[TBL] [Abstract][Full Text] [Related]
12. [Intellectual development after relaxing the diet at the age of 5 years in typical phenylketonuria].
Abadie V; Rey F; Plainguet F; Rey J
Arch Fr Pediatr; 1992 Nov; 49(9):773-8. PubMed ID: 1300964
[TBL] [Abstract][Full Text] [Related]
13. Intellectual assessment of 111 four-year-old children with phenylketonuria.
Dobson JC; Williamson ML; Azen C; Koch R
Pediatrics; 1977 Dec; 60(6):822-7. PubMed ID: 600594
[TBL] [Abstract][Full Text] [Related]
14. Late-treated phenylketonuria and partial reversibility of intellectual impairment.
Grosse SD
Child Dev; 2010; 81(1):200-11. PubMed ID: 20331662
[TBL] [Abstract][Full Text] [Related]
15. [Psychosocial aspects of the treatment of phenylketonuria].
Schweitzer S; Wolff G; Brodehl J
Klin Padiatr; 1987; 199(2):90-4. PubMed ID: 3586565
[TBL] [Abstract][Full Text] [Related]
16. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.
Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ
Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792
[TBL] [Abstract][Full Text] [Related]
17. Loss of intellectual function in children with phenylketonuria after relaxation of dietary phenylalanine restriction.
Seashore MR; Friedman E; Novelly RA; Bapat V
Pediatrics; 1985 Feb; 75(2):226-32. PubMed ID: 3969322
[TBL] [Abstract][Full Text] [Related]
18. Neurocognitive functioning in adults with phenylketonuria: results of a long term study.
Weglage J; Fromm J; van Teeffelen-Heithoff A; Möller HE; Koletzko B; Marquardt T; Rutsch F; Feldmann R
Mol Genet Metab; 2013; 110 Suppl():S44-8. PubMed ID: 24071437
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of genotype and intellectual phenotype in untreated phenylketonuric children].
Yuan L; Fang B; Wang M; Wang T; Huang S; Yang T; Zhao S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Oct; 15(5):297-9. PubMed ID: 9758878
[TBL] [Abstract][Full Text] [Related]
20. Potential role of tetrahydrobiopterin in the treatment of maternal phenylketonuria.
Trefz FK; Blau N
Pediatrics; 2003 Dec; 112(6 Pt 2):1566-9. PubMed ID: 14654666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
